JUBLIA

Biovail Laboratories International SRL

Application Filed: 2006-04-17
Trademark Application Details
Trademark Logo JUBLIA

Status


606
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED
Research OneLook Acronym Finder
Serial Number78862951
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeJames R. Menker
Attorney NameChristopher L. Graff
Attorney Docket NumberVPBV002
Law Office AssignedL20
Employee NameWEBSTER, WILLIAM M

Timeline

2006-04-17Application Filed
2007-11-13Published for Opposition
2009-02-17Location: INTENT TO USE SECTION
2011-03-07Abandon
2011-03-07Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: Biovail Laboratories International SRL
Entity StatementInternational Society
AddressWelches Christ Church BB BB17154
Legal Entity Type
Legal Entity State BB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Christopher L. Graff
PIRKEY BARBER PLLC
600 Congress Ave., Suite 2120
Austin TX 78701

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2006-04-211 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER2006-09-132 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2006-09-133 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2006-09-134 GNRT F:First Action
TEAS RESPONSE TO OFFICE ACTION RECEIVED2007-03-135 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2007-03-136 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2007-03-147 TEME I:Incoming Correspondence
FINAL REFUSAL WRITTEN2007-03-158 CNFR R:Renewal
FINAL REFUSAL E-MAILED2007-03-159 GNFR O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2007-09-0610 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2007-09-0611 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2007-09-0612 TEME I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2007-09-0613 TCCA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2007-09-1014 CNSA P:
TEAS CHANGE OF CORRESPONDENCE RECEIVED2007-09-2915 TCCA I:Incoming Correspondence
ASSIGNED TO LIE2007-10-1016 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED2007-10-1017 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION2007-10-2418 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION2007-11-1319 PUBO A:Allowance for Publication
FAX RECEIVED2007-11-1520 FAXX I:Incoming Correspondence
ASSIGNED TO PETITION STAFF2007-11-2021 APET A:Allowance for Publication
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED2007-11-2322 CHPB I:Incoming Correspondence
NOA MAILED - SOU REQUIRED FROM APPLICANT2008-02-0523 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED2008-08-0124 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2008-08-0125 EXT1 S:
EXTENSION 1 GRANTED2008-08-0126 EX1G S:
TEAS CHANGE OF OWNER ADDRESS RECEIVED2009-01-2227 COAR I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2009-01-2228 CHAN I:Incoming Correspondence
TEAS EXTENSION RECEIVED2009-02-0429 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2009-02-1730 AITU A:Allowance for Publication
EXTENSION 2 FILED2009-02-0431 EXT2 S:
EXTENSION 2 GRANTED2009-02-1832 EX2G S:
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2009-06-1733 ASCK I:Incoming Correspondence
TEAS EXTENSION RECEIVED2009-07-3034 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2009-07-3035 EXT3 S:
EXTENSION 3 GRANTED2009-07-3136 EX3G S:
TEAS EXTENSION RECEIVED2010-02-0337 EEXT I:Incoming Correspondence
EXTENSION 4 FILED2010-02-0338 EXT4 S:
EXTENSION 4 GRANTED2010-02-0839 EX4G S:
TEAS EXTENSION RECEIVED2010-08-0340 EEXT I:Incoming Correspondence
EXTENSION 5 FILED2010-08-0341 EXT5 S:
EXTENSION 5 GRANTED2010-08-0642 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2010-08-0743 EXRA E:E-Mail
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2010-10-1344 ASCK I:Incoming Correspondence
ABANDONMENT - NO USE STATEMENT FILED2011-03-0745 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2011-03-0746 MAB6 O:Outgoing Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2011-03-2347 ASCK I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2014-01-2248 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2014-01-2249 ARAA I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed